CVS Health Corporation $CVS Shares Newly Bought by Axecap Investments LLC

Axecap Investments LLC bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 32,837 shares of the pharmacy operator’s stock, valued at approximately $2,814,000. CVS Health makes up approximately 1.7% of Axecap Investments LLC’s portfolio, making the stock its 21st biggest position.

A number of other institutional investors have also recently modified their holdings of the business. Kilter Group LLC purchased a new position in CVS Health during the second quarter worth approximately $27,000. Global Trust Asset Management LLC grew its holdings in CVS Health by 344.8% in the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 300 shares during the period. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health in the second quarter valued at approximately $30,000. Beaird Harris Wealth Management LLC increased its position in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 195 shares in the last quarter. Finally, Timbuktu Capital Management LLC acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $31,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Argus increased their target price on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, August 19th. Sanford C. Bernstein reissued an “outperform” rating and issued a $112.00 price target on shares of CVS Health in a report on Wednesday, September 9th. Barclays increased their price objective on shares of CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Piper Sandler set a $112.00 target price on shares of CVS Health in a research report on Wednesday, September 9th. Finally, Truist Financial boosted their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $107.80.

CVS Health Trading Up 2.3%

Shares of CVS stock opened at $94.77 on Wednesday. The stock’s fifty day moving average is $91.70 and its two-hundred day moving average is $93.49. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The firm has a market capitalization of $121.21 billion, a P/E ratio of 25.07, a PEG ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the previous year, the company posted $1.81 EPS. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be given a dividend of $0.6650 per share. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s payout ratio is presently 70.37%.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Opportunity to gain pharmacy customers: CVS is targeting customers displaced by Walgreens and Rite Aid store closures. The initiative could support prescription volume, retail sales and customer retention if CVS successfully converts those patients. CVS targets former Walgreens, Rite Aid customers after 1,000 stores close
• Positive Sentiment: Aetna administrative improvements: CVS says Aetna is streamlining prior authorizations, approving more than 95% of eligible requests within 24 hours and expanding bundled approvals. Faster decisions could improve member and provider satisfaction while reducing administrative costs. How CVS’ Aetna Is Advancing Efforts to Reduce Administrative Burden
• Positive Sentiment: MinuteClinic expansion: Three new Massachusetts locations—including the first in Boston—expand CVS’s healthcare footprint and may increase patient traffic, service revenue and cross-selling opportunities. MinuteClinic opens three new retail medical clinics
• Neutral Sentiment: Leadership transition: Chief Information Officer Amaresh Siva is leaving CVS to become Alaska Airlines’ chief information technology officer. The departure may create near-term technology and AI execution uncertainty, though it does not directly change CVS’s financial outlook. Alaska Airlines taps CVS Health executive for new technology role
• Negative Sentiment: Industry and valuation concerns: Coverage highlights pressure from rising medical costs across managed care, uncertainty surrounding Medicare Advantage plan availability and technical weakness after CVS raised its outlook. These issues could limit valuation expansion despite the company’s improved earnings guidance. Management raised the bar for CVS Health stock

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.